Denmark
About Bavarian Nordic A/S
Bavarian Nordic A/S is a biopharmaceutical company specializing in the development, manufacturing, and supply of life-saving vaccines. Established in 1992, the company is headquartered in Hellerup, Denmark, and operates globally across multiple regions.
Key Products
- Smallpox & Monkeypox Vaccines: Marketed under the names IMVAMUNE, IMVANEX, and JYNNEOS.
- Rabies Vaccine: Available as Rabipur/RabAvert for human use.
- Tick-Borne Encephalitis Vaccine: Sold under the brand name Encepur.
- Cholera Vaccine: Vaxchora, an oral immunization solution.
- Typhoid Fever Vaccine: Vivotif/Typhoral, an oral vaccine.
Pipeline Development
The company is actively developing MVA-BN WEV, a potential treatment for encephalitis viruses.
Global Operations
Bavarian Nordic A/S serves markets in the United States, Denmark, Canada, France, Germany, Singapore, Finland, the Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and other international locations.
